Quest Diagnostics Inc. DGX is investing in advanced diagnostics to deliver and scale innovative services that improve patient care and drive growth. The company’s growth strategy includes pursuing ...

Valued at a market cap of $20.1 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing, ...

This was the stock's second consecutive day of gains.

GoPath Diagnostics, a leading provider of molecular and digital pathology services, today announced the launch of DiabetesNow, a comprehensive genetic test developed to support the diagnosis ...

India have won just three out of their last 10 Test matches, losing seven and drawing one in the meantime. They won the home series against Bangladesh, but lost to New Zealand at home and to ...

England have won 6 out of their last 10 Test matches, losing 4 in the meantime. They won two matches of their three-match series against Sri Lanka at home, followed by a 2-1 away series loss ...

Quest will develop a blood test to detect one or more cancers, including colorectal, lung, breast, pancreatic, ovarian, liver, prostate, esophageal and stomach, based on MD Anderson technology.

Amid the significant appreciation of the New Taiwan dollar against the US dollar, Sporton reported consolidated revenue of NT$365 million (approx. US$12.2 million) for May 2025, a year-over-year ...